Company patents
SAKATA SEED CORPORATION
SAKATA SEED CORPORATION's patent strategy is overwhelmingly concentrated in agriculture, with 97.5% of its portfolio in New Plants / Plant Reproduction, which saw a significant 200.0% growth in 2025. Surprisingly, the company also shows an emerging focus in pharma_biotech, with Genetic & Microbiological Assays representing 20.0% of its portfolio and experiencing 200.0% growth in 2025, and a new patent in Acyclic / Carbocyclic Compounds so far in 2026, indicating a diversification beyond its core agricultural roots.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
40 US filings (since 2023) · 3 categories · 5 themes
Development and characterization of novel plant varieties or cultivars, including field crops, vegetables, fruits, and ornamental plants, focusing on improved agronomic performance, aesthetic qualities, or specific product characteristics.
Methods and compositions for introducing, modifying, or expressing foreign genetic material within plant cells to confer new traits, produce novel compounds, or enhance existing characteristics.
Utilization of specific DNA sequences (markers) to identify, select, or characterize plant varieties or traits, enabling more efficient breeding, quality control, and intellectual property protection.
Engineering or breeding plants to exhibit enhanced resistance or tolerance to pathogens (fungi, bacteria, viruses) or pests, often involving the identification and introduction of specific resistance genes or genomic regions.
In vitro techniques for cultivating plant cells, tissues, or organs under sterile conditions to regenerate whole plants, produce secondary metabolites, or facilitate genetic manipulation.
Patents
Showing 1-10 of 71